Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients.

Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients.

To demonstrate the non-inferiority of T4030 unpreserved eye drops compared to Ganfort® UD in terms of efficacy.

Efficacy Parameters IOP assessment in each eye

Inclusion Criteria:

• Informed consent signed and dated*
• Patient aged ≥18 years old
• Both eyes with a central corneal thickness assessment ≥500 µm and ≤600 μm a
• Both eyes with diagnosed ocular hypertension or open angle glaucoma

Exclusion Criteria:

• History of narrow angle and/or angle closure glaucoma
• Advanced stage of glaucoma